The effect of rituximab on mobilization with AMD3100 plus G-CSF in patients with relapsed or refractory NHL or HD

被引：0
|
作者：
Kaufman, Jonathan. L. [1 ]
Cook, Amanda M. [1 ]
Flowers, Christopher [1 ]
Langston, Amelia A. [1 ]
Lonial, Sagar [1 ]
Lechowicz, Mary Jo [1 ]
Khoury, H. Jean [1 ]
Calandra, Gary [2 ]
Waller, Ned [1 ]
机构：
[1] Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA USA
[2] Genzyme Corp, Cambridge, MA USA
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1912
引用
收藏
页码：568A / 568A
页数：1
相关论文
共 50 条
  • [1] The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone
    Flomenberg, N
    Devine, SM
    DiPersio, JF
    Liesveld, JL
    McCarty, JM
    Rowley, SD
    Vesole, DH
    Badel, K
    Calandra, G
    BLOOD, 2005, 106 (05) : 1867 - 1874
  • [2] AMD3100 IN COMBINATION WITH G-CSF RESTORES THE IMPAIRED MOBILIZATION WITH G-CSF ALONE IN THE THALASSEMIC MOUSE MODEL
    Yannaki, E.
    Psatha, N.
    Demertzi, M.
    Athanasiou, E.
    Bougiouklis, D.
    Arsenakis, M.
    Anagnostopoulos, A.
    Fassas, A.
    EXPERIMENTAL HEMATOLOGY, 2009, 37 (09) : S81 - S81
  • [3] EFFECT OF PLERIXAFOR (AMD 3100) PLUS G-CSF ON TUMOR CELL MOBILIZATION AMONG PATIENTS WITH LYMPHOMA
    DiPersio, J. F.
    Bridger, G.
    Calandra, G.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (02) : 37 - 37
  • [4] Mobilization of bone marrow stem/progenitor cells by AMD3100 or G-CSF is impaired in diabetes
    Vasam, Goutham
    Bartelmez, Stephen
    Jarajapu, Yagna
    FASEB JOURNAL, 2014, 28 (01):
  • [5] Hematopoietic stem cell mobilization with Mozobil (AMD3100) + G-CSF in a thalassemic mouse model
    Yannaki, E.
    Psatha, N.
    Sgouramalli, E.
    Athanasiou, E.
    Bougiouklis, D.
    Arsenakis, M.
    Fassas, A.
    Anagnostopoulos, A.
    HUMAN GENE THERAPY, 2010, 21 (10) : 1459 - 1459
  • [6] A Phase II Study of Plerixafor (AMD3100) plus G-CSF for Autologous Hematopoietic Progenitor Cell Mobilization in Patients with Hodgkin Lymphoma
    Cashen, Amanda
    Lopez, Sandra
    Gao, Feng
    Calandra, Gary
    MacFarland, Ron
    Badel, Karin
    DiPersio, John
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (11) : 1253 - 1261
  • [7] Successful stem cell mobilization rescue by AMD3100 (Plerixafor) plus G-CSF for patients who failed primary mobilization: Results from the phase III (3101-NHL) study
    Micallef, Ivana
    Stiff, Patrick J.
    DiPersio, John F.
    Maziariz, Richard Thomas
    McCarty, John M.
    Angel, Jennifer
    Bridger, Gary
    Calandra, Gary
    BLOOD, 2007, 110 (11) : 185A - 186A
  • [8] Kinetics of autologous stem cell mobilization failure: Comparison of AMD3100/G-CSF, G-CSF, GM-/G-CSF, and chemotherapy/G-CSF on remobilization success.
    DiPersio, John F.
    Smith, Angela
    Sempek, Dianne
    Baker, Albert
    Jiang, Steven
    Vij, Ravi
    Cashen, Amanda
    Westervelt, Peter
    BLOOD, 2006, 108 (11) : 965A - 965A
  • [9] Kinetics of autologous stem cell mobilization failure: Comparison of AMD3100/G-CSF, G-CSF, GM-IG-CSF, and chemotherapy/g-csf on remobilization success
    DiPersio, J. F.
    Smith, A.
    Sempek, D.
    Baker, A.
    Jiang, S.
    Vij, P.
    Cashen, A.
    Westervelt, P.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (02) : 8 - 8
  • [10] AMD3100 plus G-CSF mobilizes the majority of non-Hodgkin's lymphoma (NHL), multiple myeloma (MM), and Hodgkin's disease (HD) patients who failed prior mobilization with other regimens
    Calandra, G.
    McCarty, J.
    McGuirk, J.
    Barlogie, B.
    Crocker, S. -A.
    Badel, K.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (02) : 8 - 8
12345